Skip to main content
. 2020 Sep 27;12(9):574–595. doi: 10.4254/wjh.v12.i9.574

Figure 1.

Figure 1

Liver histopathology of acute liver injury in a patient ingesting Ashwagandha. A and B: Percutaneous liver biopsy revealed severe canalicular cholestasis along with moderate portal inflammation [A, hematoxylin and eosin stain (H&E), 40 × and B, H&E stain, 400 ×)]; C: The polyherbal formulation containing Ashwagandha, retrieved from the patient is shown in C. The patient had an uneventful course with resolution of symptoms and normalization of liver tests at 2 mo.